NCT00586976View on ClinicalTrials.gov

A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2008

Conditions
Cardiac Surgery
Interventions
DRUG

Ropivacaine

0.3% ropivacaine infusion at 4 ml/hr for 64 hours.

DRUG

Normal saline

Normal saline infusion at 4 ml/hour for 64 hours.

Trial Locations (1)

55905

Mayo Clinic College of Medicine, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Stryker Nordic

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00586976 - A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery | Biotech Hunter | Biotech Hunter